Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-03-30 01:53 | 2021-03-26 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director | Retail-Drug Stores and Proprietary Stores | OPT+S | $74.73 | 270,650 | $20,225,675 | 524,026 | -34.1% |
| 2021-01-22 01:17 | 2021-01-19 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $77.00 | 62,893 | $4,842,761 | 523,329 | -10.7% |
| 2020-01-18 00:31 | 2020-01-15 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $74.79 | 266,476 | $19,929,740 | 437,021 | -37.9% |
| 2019-02-05 00:17 | 2019-02-01 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $64.51 | 166,368 | $10,732,400 | 330,209 | -33.5% |
| 2019-01-11 00:26 | 2019-01-08 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $69.04 | 166,368 | $11,486,047 | 330,209 | -33.5% |
| 2017-09-15 23:14 | 2017-09-13 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $83.07 | 241,150 | $20,032,331 | 299,255 | -44.6% |
| 2017-02-04 00:11 | 2017-02-01 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $78.32 | 76,494 | $5,991,010 | 242,212 | -24.0% |
| 2016-05-06 23:26 | 2016-05-05 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $105.00 | 38,247 | $4,015,935 | 242,134 | -13.6% |
| 2016-03-12 00:05 | 2016-03-09 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $100.00 | 38,247 | $3,824,700 | 223,040 | -14.6% |
| 2016-02-03 00:17 | 2016-02-01 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $96.14 | 46,393 | $4,460,010 | 161,628 | -22.3% |
| 2016-01-14 00:16 | 2016-01-11 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $95.00 | 46,393 | $4,407,335 | 161,613 | -22.3% |
| 2015-01-07 01:33 | 2015-01-05 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $94.30 | 144,144 | $13,592,779 | 76,129 | -65.4% |
| 2014-01-04 00:34 | 2014-01-02 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $70.76 | 228,875 | $16,194,554 | 117,033 | -66.2% |
| 2012-07-03 21:54 | 2012-07-02 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $46.96 | 161,359 | $7,576,612 | 147,381 | -52.3% |
| 2011-05-13 22:32 | 2011-05-12 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $38.01 | 80,000 | $3,040,928 | 147,286 | -35.2% |
| 2011-04-08 23:02 | 2011-04-06 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $36.00 | 144,822 | $5,214,200 | 147,286 | -49.6% |
| 2011-01-06 00:07 | 2011-01-03 | CVS | CVS HEALTH Corp | MERLO LARRY J | Officer; President and COO | Retail-Drug Stores and Proprietary Stores | OPT+S | $34.87 | 80,000 | $2,789,832 | 143,052 | -35.9% |
| 2010-12-08 00:11 | 2010-12-03 | CVS | CVS HEALTH Corp | MERLO LARRY J | Officer; President and COO | Retail-Drug Stores and Proprietary Stores | OPT+S | $32.41 | 244,822 | $7,934,583 | 143,052 | -63.1% |
| 2009-06-19 22:51 | 2009-06-17 | CVS | CVS HEALTH Corp | MERLO LARRY J | Officer; Executive Vice President | Retail-Drug Stores and Proprietary Stores | OPT+S | $31.06 | 180,000 | $5,591,646 | 145,912 | -55.2% |
| 2007-08-09 23:12 | 2007-08-07 | CVS | CVS HEALTH Corp | MERLO LARRY J | Officer; Executive Vice President | Retail-Drug Stores and Proprietary Stores | OPT+S | $37.46 | 330,440 | $12,379,142 | 134,267 | -71.1% |
| 2006-12-08 00:30 | 2006-12-06 | CVS | CVS HEALTH Corp | MERLO LARRY J | Officer; Executive Vice President | Retail-Drug Stores and Proprietary Stores | OPT+S | $29.76 | 131,486 | $3,912,721 | 100,954 | -56.6% |
| 2005-03-11 00:25 | 2005-03-10 | CVS | CVS HEALTH Corp | MERLO LARRY J | Officer; Executive Vice President | Retail-Drug Stores and Proprietary Stores | OPT+S | $52.62 | 83,702 | $4,404,232 | 15,749 | -84.2% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.